Join us for an educational webinar on RSV Disease Prevention in Practice, designed for primary care healthcare professionals. This session will focus on identifying eligible patients, discussing individual RSV risk, and the practical steps to vaccinate confidently in everyday practice.
AREXVY is available on the National Immunisation Program for adults aged ≥75 years and Aboriginal and Torres Strait Islander peoples aged ≥60 years1 and as a private script for adults aged ≥60 years and adults aged 50-59 years at increased risk of RSV disease.
For more information on the NIP, refer to your State or Territory Health Department.
Learning Objectives
By the end of this meeting, participants will be able to:
- Identify patients who are eligible for RSV vaccination
- Educate patients on their individual risk of RSV disease and the efficacy and safety profile of AREXVY
- Vaccinate with confidence by learning the practical steps to administer AREXVY in everyday practice
Location: Virtual
Date: Wednesday 27 May 2026
Time: 7:00 – 8:00pm AEST